<DOC>
	<DOCNO>NCT01248754</DOCNO>
	<brief_summary>The 18F-FDOPA PET tracer amino acid analogue use visualize high-grade glioma clearly identify diagnostic MRI . Use 18F-FDOPA PET permit neurosurgeon achieve complete resection frequently .</brief_summary>
	<brief_title>Positron Emission Tomography ( PET ) With 3,4-dihydroxy-6-18F-fluoro-L-enylalanine ( 18F-FDOPA ) Study</brief_title>
	<detailed_description />
	<mesh_term>Dihydroxyphenylalanine</mesh_term>
	<criteria>Contrastenhancing mass diagnostic brain CT MRI strongly suggest diagnosis WHO grade III IV glioma Karnofsky Performance status ( KPS ) ≥ 70 Age ≥18 year Subject able understand consent study Glomerular filtration rate ( GFR ) ≥ 45 ml/minute Indication urgent craniotomy relieve mass effect Only stereotactic biopsy indicate tumour locate eloquent brain . The enhancement T1 MRI sequence involve abuts basal ganglia Previous intracranial malignancy invasive malignancy unless free disease &gt; 5 year Prior cranial irradiation Contraindications systemic radiation exposure : pregnancy breast feed Subject exceeds weight limit PET scanner bed ( 204.5 kg ) Subjects take medication Levodopa treatment Parkinson 's Disease Allergies contraindication CT contrast MRI contrast</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Neurosurgery</keyword>
	<keyword>Neuronavigation</keyword>
	<keyword>Positron emission tomography</keyword>
	<keyword>FDOPA</keyword>
</DOC>